Form 4: Teladoc Health's Chief Medical Officer Reports Stock Sale

Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, sold 1,537 shares of common stock on August 5, 2024, at a price of $7.33 per share.

Summary

• On August 5, 2024, Vidya Raman-Tangella, the Chief Medical Officer of Teladoc Health, sold 1,537 shares of the company's common stock.
• The sale was executed at a price of $7.33 per share.
• Following the transaction, Raman-Tangella directly owns 32,130 shares of Teladoc Health.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a stock sale by an executive under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under 10b5-1 plans are less informative because they are pre-scheduled.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates